Drug Profile
Dihydroergotamine mesilate - POZEN
Alternative Names: Dihydroergotamine mesylate injection - POZEN; MT-300Latest Information Update: 18 Jul 2018
Price :
$50
*
At a glance
- Originator POZEN
- Class Antimigraines; Ergotamines; Mesylates; Small molecules
- Mechanism of Action Serotonin 1B receptor agonists; Serotonin 1D receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Migraine
Most Recent Events
- 13 Jul 2018 Valeant Pharmaceuticals International is now called Bausch Health Companies
- 02 Mar 2005 Xcel Pharmaceuticals has been acquired by, and merged into, Valeant Pharmaceuticals International
- 04 Nov 2004 Preregistration for Migraine in USA (Injection)